U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Tue Apr 01 18:57:49 GMT 2025
Edited
by admin
on Tue Apr 01 18:57:49 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
X6HV7Q6XP4
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
HISTONE DEACETYLASE 6
Common Name English
HDAC-6
Preferred Name English
HDAC6
Common Name English
Code System Code Type Description
UNIPROT
Q9UBN7
Created by admin on Tue Apr 01 18:57:49 GMT 2025 , Edited by admin on Tue Apr 01 18:57:49 GMT 2025
PRIMARY
FDA UNII
X6HV7Q6XP4
Created by admin on Tue Apr 01 18:57:49 GMT 2025 , Edited by admin on Tue Apr 01 18:57:49 GMT 2025
PRIMARY
Related Record Type Details
Structure of CHR-2847
INHIBITOR -> TARGET
Pan HDAC inhibitor
Structure of BG-45
INHIBITOR -> TARGET
Structure of NANATINOSTAT
WEAK INHIBITOR->TARGET
IC50
Structure of N-HYDROXY-3-(3-(PHENETHYLSULFAMOYL)PHENYL)ACRYLAMIDE
INHIBITOR -> TARGET
Structure of TACEDINALINE
NON-INHIBITOR->OFF TARGET
IC50
Structure of PANOBINOSTAT
INHIBITOR -> TARGET
IC50
Structure of IVALTINOSTAT
INHIBITOR -> TARGET
Structure of AVS-100
INHIBITOR -> TARGET
Polarize macrophages to the anti-tumoral M1 phenotype.
Structure of CITARINOSTAT
INHIBITOR -> TARGET
Structure of MPT0G-211
INHIBITOR -> TARGET
Selectivity greater than 4,000~43,000-fold over other HDAC isoforms.
IC50
Structure of ABEXINOSTAT
INHIBITOR -> TARGET
Structure of VORINOSTAT
INHIBITOR -> TARGET
Structure of TINOSTAMUSTINE
INHIBITOR -> TARGET
Structure of RESMINOSTAT
INHIBITOR -> TARGET
Structure of KA-2507
INHIBITOR -> TARGET
Structure of RICOLINOSTAT
INHIBITOR -> TARGET
IC50
Structure of MOCETINOSTAT
NON-INHIBITOR->TARGET
Structure of VALPROIC ACID
INHIBITOR -> TARGET
Structure of PURINOSTAT
INHIBITOR -> TARGET
IN-VIVO
Structure of QUISINOSTAT
WEAK INHIBITOR->TARGET
Structure of FR-135313
INHIBITOR -> TARGET
Structure of TUBASTATIN A HYDROCHLORIDE
INHIBITOR -> TARGET
Structure of JBI-802 FREE BASE
INHIBITOR -> TARGET
PRECLINICAL
IC50
Structure of PCI-34051
INHIBITOR -> TARGET
Structure of SW-100
INHIBITOR -> TARGET
IC50

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID SUBSTITUTION [1_1016] [1_1021] [1_1027] [1_1031] [1_1034] [1_1040] SITE_SPECIFIC THREONINE PHOSPHATE 3L4WX7B1EI
AMINO_ACID_SUBSTITUTION [1_1145] [1_1148] [1_1164] [1_1170] SITE_SPECIFIC C2H2-TYPE ZINC FINGER A0G4UYZ9B5
AMINO_ACID_SUBSTITUTION [1_1113] [1_1115] [1_1183] [1_1186] SITE_SPECIFIC C3H1-TYPE ZINC FINGER JKX41V9FYM
AMINO ACID SUBSTITUTION [1_22] [1_1035] SITE_SPECIFIC DEXFOSFOSERINE VI4F0K069V
AMINO_ACID_SUBSTITUTION [1_1133] [1_1136] [1_1153] [1_1160] SITE_SPECIFIC C3H1-TYPE ZINC FINGER JKX41V9FYM
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966